메인페이지 Co-Located Events INVEST FAIR

INVEST FAIR
Overview • IR Presentation from Korean listed companies in pharmaceutical & bio industry
• Introduction to new pharmaceutical products under clinical test abroad
Date Thursday, MAY 10th, 2018, 15:00~17:30
Venue Seoul COEX Hall 300
Organizer Ministry of Health and Welfare / KHIDI / Maeil Business Newspaper
Preliminary participant Domestic and overseas investors, asset management companies, venture capitalists, and pharmaceutical and bio industry officials (about 100 participants)
 
Program
Time Session Title Presenter
15 : 00 ~ 15 : 20 KOSDAQ IPO Policy
- IPO Strategy through Technology Evaluation
Byung Mo Kang, Team Leader, Korea Exchange (KOSDAQ Market Division)
15 : 20 ~ 15 : 40 Investment trend in KOSDAQ listed companies Jung Hee Lim, Executive Director, Intervest
15 : 40 ~ 15 : 50 Situation analysis on North America’s increasing investment in bio & health industry Skip Fleshman, Partner, Asset Management Ventures
15 : 50 ~ 16 : 05 IR Presentation: LegoChem Biosciences Inc. Intro: Mahn Soon Hwang, Senior Managing Director, Korea Investment Partners Speaker: Jeiwook Chae, Chief Business Officer, LegoChem Biosciences
16 : 05 ~ 16 : 20 IR Presentation: Co., Ltd. Intro: Joonil Kil, Partner, NHN Investment Speaker: Seok Geun Choi, Vice President, Eubiologics
16 : 20 ~ 16 : 30 China health industry investment trends and strategy Kevin Lin, Vice Director, Fortune Capital Co. Ltd.
16 : 30 ~ 16 : 45 IR Presentation: Peptron Inc. Intro: Jung Seob Shin, Managing Director, KB Investment
Speaker: Hoil Choi, Founder & CEO, Peptron
16 : 45 ~ 17 : 00 IR Presentation: Amicogen, Inc. Intro: Gil Tae Wie, Manager,Mirae Asset Speaker: Jun Ho Kim, Director, Amicogen
17 :00 ~ 17 : 10 Global Commercialization Ted Byung Chan Moon, Managing Director, RM Global
17 : 10 ~ 17 : 25 IR Presentation: Eyegene Inc. Intro: Tae Hee Kim, General Manager, Neoplux Investment  Company, Speaker: Stan Kim, Managing Director, Head of Business Development, Eyegene
* The schedule and contents are subject to change according to circumstances.
 
Contact
TEL: +82-2-742-1915 / Email: mincomm2010@daum.net